SCHEMBL10713193

SCHEMBL10713193

CSC1C(=O)Nc2c1cc(-c1ccccc1)cc2[N+](=O)[O-]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRHBP P24387 1/20 0.44
▸ CRHR2 Q13324 1/20 0.44
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ KDM4A O75164 1/20 0.41
▸ TDP2 O95551 1/20 0.41
▸ KDM4C Q9H3R0 1/20 0.41
▸ APOBEC3G Q9HC16 1/20 0.41
▸ PGR P06401 1/20 0.37
▸ CYP11B1 P15538 1/20 0.37
▸ CYP11B2 P19099 1/20 0.37
▸ FBP1 P09467 1/20 0.36
▸ TDP1 Q9NUW8 4/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ HPRT1 P00492 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10713691 0.89 GSK3B (0.40) CRHBPCRHR2MEN1KMT2AKDM4A
SCHEMBL10712895 0.85 MEN1 (0.38) MEN1KMT2AKDM4ATDP2KDM4C
SCHEMBL10714792 0.80 ALDH1A1 (0.36) PGRALDH1A1PTGS2GSK3B
SCHEMBL10711940 0.79 MEN1 (0.40) CRHBPCRHR2MEN1KMT2AKDM4A
SCHEMBL10715084 0.79 PTGS2 (0.39) MEN1KMT2AKDM4ATDP2KDM4C
SCHEMBL10711646 0.78 MEN1 (0.38) MEN1KMT2AKDM4ATDP2KDM4C
SCHEMBL10711924 0.76 PGR (0.38) PGRTDP1ALDH1A1MAPTRECQL
SCHEMBL10712554 0.73 KMT2A (0.45) MEN1KMT2AKDM4ATDP2KDM4C
SCHEMBL10711782 0.73 PGR (0.46) MEN1KMT2AKDM4ATDP2KDM4C
SCHEMBL10711443 0.72 PGR (0.49) MEN1KMT2APGRALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4670566-A ANTIIFLAMMATORY AGENTS, ANTICOAGULANTS A. H. ROBINS COMPANY, INCORPORATED (US) 1987-06-02 — — US disclosed
US-4440785-A Methods of using 2-aminobiphenylacetic acids, esters, and metal salts thereof to treat inflammation A. H. ROBINS COMPANY, INC. (US) 1984-04-03 — — US disclosed
Send feedback